Coronary Artery Disease
Acute myocardial infarction percutaneous coronary intervention in the patient with chronic renal disease—Two strikes trying to avoid the third
First published: 29 October 2007
No abstract is available for this article.
REFERENCES
- 1
Antman EM,Anbe DT,Armstrong PA, et al.
ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—Executive summary: A report of the American college of cardiology/American heart association task force on practice guidelines.
Circulation
2004;
110:
588–636.
- 2
Jacobs AK,Antman EM,Faxon DP, et al.
Development of systems of care for ST-elevation myocardial infarction patients: Executive summary.
Circulation
2007;
116:
217–230.
- 3
Vasu S,Gruberg L,Brown DL.
The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction.
Cathet Cardiovasc Interv
2007;
70:
701–705.
- 4
McCullough PA,Wolyn R,Rocher LL, et al.
Acute renal failure after PCI: Incidence, risk factors, and relationship to mortality.
Am J Med
1997;
103:
368–375.
- 5
Rihal CS,Textor SC,Grill DE, et al.
Incidence and prognostic importance of acute renal failure after PCI.
Circulation
2002;
105:
2259–2264.
- 6
Mehran R,Aymong ED,Nikolsky E, et al.
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation.
J Am Coll Cardiol
2004;
44:
1393–1399.
- 7
National Kidney Foundation.
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification.
Am J Kidney Dis
2002;
39 (
Suppl 1):
S1–S266.
- 8
Schweiger MJ,Chambers CE,Davidson CJ, et al.
Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures.
Cathet Cardiovasc Interv
2006;
69:
135–140.
